Drugs / Gonadotropin Releasing Hormone Agonists (GNRH)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT07848828 Comparator | Aug 2026 → Jul 2028 expected | dysautonomia, hypertensive disorder, kidney disorder, prostate cancer | Virginia Commonwealth University | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Gonadotropin Releasing Hormone Agonists (GNRH) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07848828 ↗ |